June 2025
Dental Carpule Market is expected to grow significantly over the forecast period. It is projected to register at a 5.6% CAGR over the forecast period.
Dental carpules are liquid medicine containing cartridges that are inserted into the teeth during dental procedures. It has a puncturable cap and inserted with the help of syringe. The increasing number of dental procedures, rising dental diseases, and technological advancements in the dental industry are likely to provide favorable conditions for the growth of the market during the forecast period.
Various other factors, such as the growing dental tourism and increasing awareness about dental procedures, are also expected to propel the growth of the market.
However, the high cost of dental procedures and the grey market for dental products can hamper market growth over the forecast period.
Segmentation
The global dental carpule market is segmented based on material, component, end user, and region.
The global market for dental carpule, by material, is segmented into glass carpule, plastic carpule, and metal carpule.
Based on component, the global market is segmented into lidocaine, bupivacaine, articaine, mepivacaine, prilocaine, etidocaine, ropivacaine, and others.
Based on end users, the global market is segmented into hospitals & dental clinics, home care, and others.
Key Players
Some of the key players in the global dental carpule market are GlaxoSmithKline, AstraZeneca, Gilead Sciences, Inc., Sanofi, Merck & Co., Inc., F. Hoffmann-La Roche AG, Pfizer Inc, Novartis AG, Septodont Holding, and Proficient Rx LP.
Market Segmentation
Global Dental Carpule Market, by Material
Global Dental Carpule Market, by Component
Global Dental Carpule Market, by End User
June 2025
May 2025
January 2025
July 2025